| [1] |
Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease[J]. BMJ, 2020, 369: m1067.
|
| [2] |
Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care[J]. Nat Rev Rheumatol, 2020, 16(12): 702-714.
|
| [3] |
Kamisawa T, Zen Y, Nakazawa T, et al. Advances in IgG4-related pancreatobiliary diseases[J]. Lancet Gastroenterol Hepatol, 2018, 3(8): 575-585.
|
| [4] |
Deshpande V. The pathology of IgG4-related disease: critical issues and challenges[J] .Semin Diagn Pathol, 2012, 29(4): 191-196.
|
| [5] |
Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details[J]. Mod Rheumatol, 2012, 22(1): 1-14.
|
| [6] |
Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients[J]. Arthritis Rheumatol, 2015, 67(9): 2466-2475.
|
| [7] |
Stone JH, Zen Y, Deshpande V. IgG4-related disease[J]. N Engl J Med, 2012, 366(6): 539-551.
|
| [8] |
Lee LIT, Gillibrand R, Mukerjee D, et al. Isolated pulmonary IgG4-related disease mimicking lung malignancy[J]. BJR Case Rep, 2017, 3(3): 20 160 134.
|
| [9] |
Kriegsmann M, Gomez C, Heil J, et al. IgG4-related sclerosing mastitis in a 49-year-old patient with multiple, tumor-like nodules-diagnostic accuracy of core needle biopsy[J]. Breast J, 2019, 25(6): 1251-1253.
|
| [10] |
Erivwo P, Turashvili G. Pathology of IgG4-related sclerosing mastitis[J]. J Clin Pathol, 2021, 74(8): 475-482.
|
| [11] |
Bateman AC, Ashton-Key MR, Jogai S. Lymph node granulomas in immunoglobulin G4-related disease[J]. Histopathology, 2015, 67(4): 557-561.
|
| [12] |
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011[J]. Mod Rheumatol, 2012, 22(1): 21-30.
|
| [13] |
Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease[J]. Arthritis Rheumatol, 2020, 79(1): 77-87.
|
| [14] |
Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192.
|
| [15] |
Erivwo P, Turashvili G. Pathology of IgG4-related sclerosing mastitis[J]. J Clin Pathol, 2021, 74(8): 475-482.
|
| [16] |
Tan ES, Friesen B, Loh SF, et al. Immunoglobulin-G4 related mastitis: a case report[J]. Int J Surg Case Rep, 2017, 37: 169-172.
|
| [17] |
Cheuk W, Chan ACL, Lam W, et al. IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases[J]. Am J Surg Pathol, 2009, 33(7): 1058-1064.
|
| [18] |
Dítě P, Trna J, Kinkor Z, et al. Unusual multiorgan immunoglobulin G4 (IgG4) inflammation: autoimmune pancreatitis, Mikulicz syndrome, and IgG4 mastitis[J]. Gut Liver, 2013, 7(5): 621-624.
|
| [19] |
Omar D, Chen Y, Cong Y, et al. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis[J]. Rheumatology (Oxford), 2020, 59(4): 718-726.
|
| [20] |
Khosroshahi A, Carruthers MN, Deshpande V, et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients[J]. Medicine (Baltimore), 2012, 91(1): 57-66.
|
| [21] |
Karim F, Paridaens D, Westenberg LEH, et al. Infliximab for IgG4-related orbital disease[J]. Ophthalmic Plast Reconstr Surg, 2017, 33(3S Suppl 1): S162-S165.
|
| [22] |
Simpson RS, Lau SKC, Lee JK. Dupilumab as a novel steroid-sparing treatment for IgG4-related disease[J]. Ann Rheum Dis, 2020, 79(4): 549-550.
|